The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and

Chen Li1, Songyi Xu, Avrum I Gotlieb

  • 1Laboratory Medicine Program, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada M5G 1L5.

Insights

Calcific aortic valve disease (CAVD) involves injury, inflammation, and cellular changes leading to valve calcification. Understanding valve interstitial cell dysfunction is key to detecting, treating, and preventing this common heart condition.

Area of Science:

  • Cardiovascular Pathobiology
  • Cellular and Molecular Medicine

Background:

  • Calcific aortic valve disease (CAVD) is a prevalent condition causing significant morbidity and mortality.
  • The exact pathogenesis of CAVD remains incompletely understood, necessitating further research.

Purpose of the Study:

  • To synthesize current in vivo and in vitro research on CAVD.
  • To propose a unifying hypothesis for CAVD development and progression.
  • To highlight the role of valve interstitial cells in CAVD pathogenesis.

Main Methods:

  • Review of experimental in vivo and in vitro studies.
  • Analysis of human in vivo research in cell and molecular pathobiology.
  • Integration of data to form a pathobiologic hypothesis.

Main Results:

  • CAVD pathogenesis involves a positive feedback loop of injury, inflammation, matrix remodeling, and physical forces.
  • Valve interstitial cell dysfunction, including altered proliferation, migration, and secretion, is central to CAVD.
  • Chondrogenesis and osteogenesis in the fibrotic valve contribute to severe clinical manifestations.

Conclusions:

  • CAVD pathogenesis is complex, involving interconnected cellular and mechanical processes.
  • Valve interstitial cell phenotypes are critical players in the disease.
  • Further research in vitro and in vivo can identify targets for CAVD detection, treatment, and prevention.

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...